世界の熱帯性痙性対麻痺治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Tropical Spastic Paraparesis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4985
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、熱帯性痙性対麻痺治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（17-アルファ-エチニルテストステロン、モガムリズマブ、その他）、用途別市場規模（病院、クリニック、外科医院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・熱帯性痙性対麻痺治療の市場動向
・企業の競争状況、市場シェア
・熱帯性痙性対麻痺治療の種類別市場規模と予測2016-2027（17-アルファ-エチニルテストステロン、モガムリズマブ、その他）
・熱帯性痙性対麻痺治療の用途別市場規模と予測2016-2027（病院、クリニック、外科医院、その他）
・熱帯性痙性対麻痺治療の北米市場規模2016-2027（アメリカ、カナダ）
・熱帯性痙性対麻痺治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・熱帯性痙性対麻痺治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・熱帯性痙性対麻痺治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・熱帯性痙性対麻痺治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（MP Biomedicals、Fujirebio, Inc.、Quest Diagnostics、DiaSorin S.p.A.、Merck）
・結論

Market Analysis and Insights: Global Tropical Spastic Paraparesis Treatment Market
The global Tropical Spastic Paraparesis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tropical Spastic Paraparesis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tropical Spastic Paraparesis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tropical Spastic Paraparesis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tropical Spastic Paraparesis Treatment market.

Global Tropical Spastic Paraparesis Treatment Scope and Market Size
Tropical Spastic Paraparesis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tropical Spastic Paraparesis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
17-Alpha-Ethinyltestosterone
Mogamulizumab
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
MP Biomedicals
Fujirebio, Inc.
Quest Diagnostics
DiaSorin S.p.A.
Merck

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tropical Spastic Paraparesis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 17-Alpha-Ethinyltestosterone
1.2.3 Mogamulizumab
1.2.4 Others
1.3 Market by Application
1.3.1 Global Tropical Spastic Paraparesis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tropical Spastic Paraparesis Treatment Market Perspective (2016-2027)
2.2 Tropical Spastic Paraparesis Treatment Growth Trends by Regions
2.2.1 Tropical Spastic Paraparesis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tropical Spastic Paraparesis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Tropical Spastic Paraparesis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Tropical Spastic Paraparesis Treatment Industry Dynamic
2.3.1 Tropical Spastic Paraparesis Treatment Market Trends
2.3.2 Tropical Spastic Paraparesis Treatment Market Drivers
2.3.3 Tropical Spastic Paraparesis Treatment Market Challenges
2.3.4 Tropical Spastic Paraparesis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tropical Spastic Paraparesis Treatment Players by Revenue
3.1.1 Global Top Tropical Spastic Paraparesis Treatment Players by Revenue (2016-2021)
3.1.2 Global Tropical Spastic Paraparesis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Tropical Spastic Paraparesis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tropical Spastic Paraparesis Treatment Revenue
3.4 Global Tropical Spastic Paraparesis Treatment Market Concentration Ratio
3.4.1 Global Tropical Spastic Paraparesis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tropical Spastic Paraparesis Treatment Revenue in 2020
3.5 Tropical Spastic Paraparesis Treatment Key Players Head office and Area Served
3.6 Key Players Tropical Spastic Paraparesis Treatment Product Solution and Service
3.7 Date of Enter into Tropical Spastic Paraparesis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tropical Spastic Paraparesis Treatment Breakdown Data by Type
4.1 Global Tropical Spastic Paraparesis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Tropical Spastic Paraparesis Treatment Forecasted Market Size by Type (2022-2027)

5 Tropical Spastic Paraparesis Treatment Breakdown Data by Application
5.1 Global Tropical Spastic Paraparesis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Tropical Spastic Paraparesis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tropical Spastic Paraparesis Treatment Market Size (2016-2027)
6.2 North America Tropical Spastic Paraparesis Treatment Market Size by Type
6.2.1 North America Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2021)
6.2.2 North America Tropical Spastic Paraparesis Treatment Market Size by Type (2022-2027)
6.2.3 North America Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2027)
6.3 North America Tropical Spastic Paraparesis Treatment Market Size by Application
6.3.1 North America Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2021)
6.3.2 North America Tropical Spastic Paraparesis Treatment Market Size by Application (2022-2027)
6.3.3 North America Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2027)
6.4 North America Tropical Spastic Paraparesis Treatment Market Size by Country
6.4.1 North America Tropical Spastic Paraparesis Treatment Market Size by Country (2016-2021)
6.4.2 North America Tropical Spastic Paraparesis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Tropical Spastic Paraparesis Treatment Market Size (2016-2027)
7.2 Europe Tropical Spastic Paraparesis Treatment Market Size by Type
7.2.1 Europe Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Tropical Spastic Paraparesis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2027)
7.3 Europe Tropical Spastic Paraparesis Treatment Market Size by Application
7.3.1 Europe Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Tropical Spastic Paraparesis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2027)
7.4 Europe Tropical Spastic Paraparesis Treatment Market Size by Country
7.4.1 Europe Tropical Spastic Paraparesis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Tropical Spastic Paraparesis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Type
8.2.1 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Application
8.3.1 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Region
8.4.1 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tropical Spastic Paraparesis Treatment Market Size (2016-2027)
9.2 Latin America Tropical Spastic Paraparesis Treatment Market Size by Type
9.2.1 Latin America Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Tropical Spastic Paraparesis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2027)
9.3 Latin America Tropical Spastic Paraparesis Treatment Market Size by Application
9.3.1 Latin America Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Tropical Spastic Paraparesis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2027)
9.4 Latin America Tropical Spastic Paraparesis Treatment Market Size by Country
9.4.1 Latin America Tropical Spastic Paraparesis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Tropical Spastic Paraparesis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Type
10.2.1 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Application
10.3.1 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Country
10.4.1 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 MP Biomedicals
11.1.1 MP Biomedicals Company Details
11.1.2 MP Biomedicals Business Overview
11.1.3 MP Biomedicals Tropical Spastic Paraparesis Treatment Introduction
11.1.4 MP Biomedicals Revenue in Tropical Spastic Paraparesis Treatment Business (2016-2021)
11.1.5 MP Biomedicals Recent Development
11.2 Fujirebio, Inc.
11.2.1 Fujirebio, Inc. Company Details
11.2.2 Fujirebio, Inc. Business Overview
11.2.3 Fujirebio, Inc. Tropical Spastic Paraparesis Treatment Introduction
11.2.4 Fujirebio, Inc. Revenue in Tropical Spastic Paraparesis Treatment Business (2016-2021)
11.2.5 Fujirebio, Inc. Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Details
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Tropical Spastic Paraparesis Treatment Introduction
11.3.4 Quest Diagnostics Revenue in Tropical Spastic Paraparesis Treatment Business (2016-2021)
11.3.5 Quest Diagnostics Recent Development
11.4 DiaSorin S.p.A.
11.4.1 DiaSorin S.p.A. Company Details
11.4.2 DiaSorin S.p.A. Business Overview
11.4.3 DiaSorin S.p.A. Tropical Spastic Paraparesis Treatment Introduction
11.4.4 DiaSorin S.p.A. Revenue in Tropical Spastic Paraparesis Treatment Business (2016-2021)
11.4.5 DiaSorin S.p.A. Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Tropical Spastic Paraparesis Treatment Introduction
11.5.4 Merck Revenue in Tropical Spastic Paraparesis Treatment Business (2016-2021)
11.5.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tropical Spastic Paraparesis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 17-Alpha-Ethinyltestosterone
Table 3. Key Players of Mogamulizumab
Table 4. Key Players of Others
Table 5. Global Tropical Spastic Paraparesis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Tropical Spastic Paraparesis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Tropical Spastic Paraparesis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Tropical Spastic Paraparesis Treatment Market Share by Regions (2016-2021)
Table 9. Global Tropical Spastic Paraparesis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Tropical Spastic Paraparesis Treatment Market Share by Regions (2022-2027)
Table 11. Tropical Spastic Paraparesis Treatment Market Trends
Table 12. Tropical Spastic Paraparesis Treatment Market Drivers
Table 13. Tropical Spastic Paraparesis Treatment Market Challenges
Table 14. Tropical Spastic Paraparesis Treatment Market Restraints
Table 15. Global Tropical Spastic Paraparesis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Tropical Spastic Paraparesis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Tropical Spastic Paraparesis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tropical Spastic Paraparesis Treatment as of 2020)
Table 18. Ranking of Global Top Tropical Spastic Paraparesis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Tropical Spastic Paraparesis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Tropical Spastic Paraparesis Treatment Product Solution and Service
Table 22. Date of Enter into Tropical Spastic Paraparesis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Tropical Spastic Paraparesis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Tropical Spastic Paraparesis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Tropical Spastic Paraparesis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Tropical Spastic Paraparesis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Tropical Spastic Paraparesis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Tropical Spastic Paraparesis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Tropical Spastic Paraparesis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Tropical Spastic Paraparesis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Tropical Spastic Paraparesis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Tropical Spastic Paraparesis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Tropical Spastic Paraparesis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Tropical Spastic Paraparesis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Tropical Spastic Paraparesis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Tropical Spastic Paraparesis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Tropical Spastic Paraparesis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Tropical Spastic Paraparesis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Tropical Spastic Paraparesis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Tropical Spastic Paraparesis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Tropical Spastic Paraparesis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. MP Biomedicals Company Details
Table 63. MP Biomedicals Business Overview
Table 64. MP Biomedicals Tropical Spastic Paraparesis Treatment Product
Table 65. MP Biomedicals Revenue in Tropical Spastic Paraparesis Treatment Business (2016-2021) & (US$ Million)
Table 66. MP Biomedicals Recent Development
Table 67. Fujirebio, Inc. Company Details
Table 68. Fujirebio, Inc. Business Overview
Table 69. Fujirebio, Inc. Tropical Spastic Paraparesis Treatment Product
Table 70. Fujirebio, Inc. Revenue in Tropical Spastic Paraparesis Treatment Business (2016-2021) & (US$ Million)
Table 71. Fujirebio, Inc. Recent Development
Table 72. Quest Diagnostics Company Details
Table 73. Quest Diagnostics Business Overview
Table 74. Quest Diagnostics Tropical Spastic Paraparesis Treatment Product
Table 75. Quest Diagnostics Revenue in Tropical Spastic Paraparesis Treatment Business (2016-2021) & (US$ Million)
Table 76. Quest Diagnostics Recent Development
Table 77. DiaSorin S.p.A. Company Details
Table 78. DiaSorin S.p.A. Business Overview
Table 79. DiaSorin S.p.A. Tropical Spastic Paraparesis Treatment Product
Table 80. DiaSorin S.p.A. Revenue in Tropical Spastic Paraparesis Treatment Business (2016-2021) & (US$ Million)
Table 81. DiaSorin S.p.A. Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Tropical Spastic Paraparesis Treatment Product
Table 85. Merck Revenue in Tropical Spastic Paraparesis Treatment Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tropical Spastic Paraparesis Treatment Market Share by Type: 2020 VS 2027
Figure 2. 17-Alpha-Ethinyltestosterone Features
Figure 3. Mogamulizumab Features
Figure 4. Others Features
Figure 5. Global Tropical Spastic Paraparesis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Tropical Spastic Paraparesis Treatment Report Years Considered
Figure 11. Global Tropical Spastic Paraparesis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Tropical Spastic Paraparesis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Tropical Spastic Paraparesis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Tropical Spastic Paraparesis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Tropical Spastic Paraparesis Treatment Market Share by Players in 2020
Figure 16. Global Top Tropical Spastic Paraparesis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tropical Spastic Paraparesis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Tropical Spastic Paraparesis Treatment Revenue in 2020
Figure 18. Global Tropical Spastic Paraparesis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Tropical Spastic Paraparesis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Tropical Spastic Paraparesis Treatment Market Share by Type (2016-2027)
Figure 22. North America Tropical Spastic Paraparesis Treatment Market Share by Application (2016-2027)
Figure 23. North America Tropical Spastic Paraparesis Treatment Market Share by Country (2016-2027)
Figure 24. United States Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Tropical Spastic Paraparesis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Tropical Spastic Paraparesis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Tropical Spastic Paraparesis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Tropical Spastic Paraparesis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Tropical Spastic Paraparesis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Tropical Spastic Paraparesis Treatment Market Share by Region (2016-2027)
Figure 40. China Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Tropical Spastic Paraparesis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Tropical Spastic Paraparesis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Tropical Spastic Paraparesis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Tropical Spastic Paraparesis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Tropical Spastic Paraparesis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Tropical Spastic Paraparesis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Tropical Spastic Paraparesis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. MP Biomedicals Revenue Growth Rate in Tropical Spastic Paraparesis Treatment Business (2016-2021)
Figure 60. Fujirebio, Inc. Revenue Growth Rate in Tropical Spastic Paraparesis Treatment Business (2016-2021)
Figure 61. Quest Diagnostics Revenue Growth Rate in Tropical Spastic Paraparesis Treatment Business (2016-2021)
Figure 62. DiaSorin S.p.A. Revenue Growth Rate in Tropical Spastic Paraparesis Treatment Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Tropical Spastic Paraparesis Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の熱帯性痙性対麻痺診断市場規模・現状・予測（2021年-2027年）

Global Tropical Spastic Paraparesis Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4984 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、熱帯性痙性対麻痺診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MRI、腰椎穿刺）、用途別市場規模（病院、診療所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の顧みられない熱帯病（NTD）治療市場規模・現状・予測（2021年-2027年）

Global Neglected Tropical Disease (NTD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4558 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、顧みられない熱帯病（NTD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院・クリニック、診断センター、学術・研究機関）、主要地域別市場規模（北米、アメリカ...

世界の顧みられない熱帯病治療薬＆ワクチン市場規模・現状・予測（2021年-2027年）

Global Neglected Tropical Diseases Drugs and Vaccine Market Size, Status and Forecast 2021-2027
QFJ1-5877 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、顧みられない熱帯病治療薬＆ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（マラリア、エボラ、デング熱、シャーガス病、リーシュマニア症、その他）、用途別市場規模（薬、ワクチン）、主要地域別市場規...

世界の顧みられない熱帯病治療市場規模・現状・予測（2021年-2027年）

Global Neglected Tropical Disease Treatments Market Size, Status and Forecast 2021-2027
QFJ1-3566 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、顧みられない熱帯病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来式治療、分子/現代式治療）、用途別市場規模（クリニックラボ、病院/クリニック、在宅医療）、主要地域別市場規模（北米、アメリカ、...

世界の熱帯魚市場規模・現状・予測（2021年-2027年）

Global Tropical Fish Market Size, Status and Forecast 2021-2027
QFJ1-2046 2021年6月 122Pages
QYResearch社発行の本調査レポートでは、熱帯魚の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（淡水熱帯魚、海水熱帯魚）、用途別市場規模（水族館、スーパー、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の熱帯性痙性対麻痺診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tropical Spastic Paraparesis Diagnosis Market The global Tropical Spastic Paraparesis Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
世界の顧みられない熱帯病（NTD）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Neglected Tropical Disease (NTD) Treatment Market The global Neglected Tropical Disease (NTD) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…
世界のαサラセミア治療市場規模・現状・予測（2021年-2027年） Alpha thalassemia causes due to deficiency or absence of alpha globin chains results in alpha thalassemia which is asymptomatic with general hematologic findings and gains silent carrier status. Market Analysis and Insights: Global Alpha Thalassemia Treatment Market The global Alpha Thalassemia Tre…
世界の顧みられない熱帯病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Neglected Tropical Disease Treatments Market The global Neglected Tropical Disease Treatments market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
世界の顧みられない熱帯病治療薬＆ワクチン市場規模・現状・予測（2021年-2027年） Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths. Market Analysis and Insights…